14 research outputs found


    Get PDF
    Self-help through self-treatment makes a countless contribution. Home remedy use is a component of health self-management, particularly among people who have experienced limited access to medical care or discrimination by the health care system. Self-care using home remedies survived for long time and it surely give effect in the easiest, safest, fastest and cheapest way. Oral diseases are a significant public health burden in India as well as across the globe. The consequence of poor oral health deteriorates the individual health and wellbeing, decrease economic productivity, and act as significant risk factors for other systemic health ailments.  Developing countries have more diverse health systems than developed countries and expenditure in oral health care is low, access to Dental healthcare is limited and restricted to emergency Dental care or pain relief. Moreover, allopathic medicine is expensive and these chemicals can have adverse effects. Hence, there is a need for alternative products and natural extracts obtained from plants which are safe and biocompatible can be considered as good alternatives. In such circumstances use of home remedies would meet the need for treating minor ailments safely. Home remedies are good and comparable methods of equal value which have met the scientific and regulatory criteria for safety and effectiveness. The purpose of this review was to evaluate some of the commonly available foods being utilized in the treatment of oral diseases at home

    Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

    Get PDF
    BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

    A Hybrid Multistage Model of Evolution of the Western Ghats at the Passive Western Continental Margin of India

    No full text

    International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module